Text Size

New Indications for Ultrasound in the Staging of Cervical Cancer

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by:
Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT00451945
First received: March 23, 2007
Last updated: June 17, 2008
Last verified: June 2008
History of Changes
  Purpose

The purpose is to investigate and evaluate two new diagnostic methods using ultrasound in the staging of cervical cancer.

  1. 3-D-ultrasound of the tumour to estimate its volume and local spread
  2. Fusion of PET/CT and ultrasound to evaluate and biopsy lymph nodes.

Condition Intervention
Cervical Cancer
 Procedure: biopsy
Device: 3d-ultrasound and fusion of UL and PET/CT

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Diagnostic
Official Title: New Indications for Ultrasound in the Staging of Cervical Cancer

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Rigshospitalet, Denmark:

Study Start Date: March 2007
Estimated Study Completion Date: March 2008
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Criteria

Inclusion Criteria:

  • Cervical cancer,
  • PET/CT pos. lymph nodes,
  • Patients over 18 years old

Exclusion Criteria:

  • Pregnancy,
  • Lactating,
  • Diabetic
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00451945

Locations
Denmark
Copenhagen univercity hospital, Department of Radiology, section of ultrasound
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
Investigators
Principal Investigator: Michael B Nielsen, MDSc Department of radiology, section of ultrasound
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00451945     History of Changes
Other Study ID Numbers: H-KF 2007-004
Study First Received: March 23, 2007
Last Updated: June 17, 2008
Health Authority: Denmark: The Danish National Committee on Biomedical Research Ethics

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
 Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female

ClinicalTrials.gov processed this record on June 18, 2013